by University of Oxford Mobile phones can worsen healthcare inequalities. Credit: Shutterstock Longstanding fears that using mobile phones may increase the risk of developing a brain tumor have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage....
by Nora Bradford, Broad Institute of MIT and Harvard MRI of a diffuse midline glioma. Credit: Dr. Jeremy Jones, radiopaedia.org. From the case rID: 68487 More children die of brain tumors than any other type of cancer. Diffuse midline gliomas (DMGs) are a particularly deadly kind, and are difficult to treat with drugs or surgery because...
by Bob Shepard, University of Alabama at Birmingham James Markert, M.D., Ph.D., chair of the Department of Neurosurgery. Credit: University of Alabama at Birmingham A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate...
by University of Plymouth Credit: Pixabay/CC0 Public Domain Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with the most common form of primary brain tumor. The breakthrough, co-funded by the charity Brain Tumor Research, is significant because, if further research is conclusive, the anti-retroviral drugs could be prescribed for patients...
by Washington University School of Medicine Credit: Unsplash/CC0 Public Domain There’s not much good that can be said about asthma, a breathing disease in which the airways become narrowed and inflamed. But there’s this: People with asthma seem to be less likely to develop brain tumors than others. And now, researchers at Washington University School of...
by Dana-Farber Cancer Institute Credit: Pixabay/CC0 Public Domain A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute. The drug combination, which blocked an overactive cell-growth signaling pathway, shrank...
by Arizona State University By analyzing brain stem cell data, Assistant Professor Christopher Plaisier and biomedical engineering doctoral student Samantha O’Connor saw the phases of the cell cycle mapped out in more detail than previously possible — the G0 resting phases, including a new, separate phase they called Neural G0, in addition to growth phases G1...
NAGOYA UNIVERSITY IMAGE: NANOWIRE SCAFFOLDS FOR THE SCREENING OF MICRORNAS FROM PATIENT-DERIVED TUMOR-ORGANOID AND URINE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS. CREDIT: TAKAO YASUI & ATSUSHI NATSUME A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings, published in the journal ACS Applied Materials...
by German Cancer Research Center Glioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0 Brain tumor cells with a certain common mutation reprogram invading immune cells. This leads to the paralysis of the body’s immune defense against the tumor in the brain. Researchers from Heidelberg, Mannheim and Freiburg discovered this mechanism, and at...
UNIVERSITY OF VIRGINIA HEALTH SYSTEM THE DISCOVERY OF THE ONCOGENE RESPONSIBLE FOR GLIOBLASTOMA COULD BE THE BRAIN TUMOR’S ACHILLES’ HEEL, SAYS HUI LI, PHD, OF THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE AND THE UVA… view more CREDIT: UVA HEALTH Scientists have identified an oncogene (a cancer-causing gene) responsible for glioblastoma, the deadliest brain tumor....
